Insider Transactions Reported by 15 Insiders of Dogwood Therapeutics, Inc.

Symbol
DWTX on Nasdaq
Location
Alpharetta, GA

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

Dogwood Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sealbond Ltd Director, Other*, 10%+ Owner $164,022,056 21 Nov 2025
William Pridgen Director $992,479 26 Feb 2024
CK Life Sciences Intl (Holdings) Inc Director, Other*, 10%+ Owner $1,993 12 Mar 2025
Angela Walsh Chief Financial Officer 05 Mar 2026
Roger Michael Gendreau Chief Medical Officer 05 Mar 2026
Conjoint Inc. Director, Other*, 10%+ Owner 12 Mar 2025
Abel de la Rosa Director 27 Jun 2025
David R. Keefer Director 27 Jun 2025
John C. Thomas Director 27 Jun 2025
Gregory Scott Duncan CHIEF EXECUTIVE OFFICER, Director 05 Mar 2026
Richard James Whitley Director 27 Jun 2025
Ralph Grosswald Svp Of Operations 05 Mar 2026
Richard Alan Burch Director 26 Feb 2024
Toh Kean Meng Melvin Director 07 Oct 2024
Yu Ying Choi Alan Abel Director 07 Oct 2024

Recent Insider Transactions by Companies or Individuals for Dogwood Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Ralph Grosswald DWTX Stock Option (right to buy) Award 82,500 82,500 05 Mar 2026 Direct
Angela Walsh DWTX Stock Option (right to buy) Award 82,500 82,500 05 Mar 2026 Direct
Roger Michael Gendreau DWTX Stock Option (right to buy) Award 82,500 82,500 05 Mar 2026 Direct
Gregory Scott Duncan DWTX Stock Option (right to buy) Award 330,000 330,000 05 Mar 2026 Direct
Gregory Scott Duncan DWTX Stock Option (right to buy) Award 460,000 460,000 04 Dec 2025 Direct
Angela Walsh DWTX Stock Option (right to buy) Award 150,000 150,000 04 Dec 2025 Direct
Ralph Grosswald DWTX Stock Option (right to buy) Award 150,000 150,000 04 Dec 2025 Direct
Roger Michael Gendreau DWTX Stock Option (right to buy) Award 150,000 150,000 04 Dec 2025 Direct
Sealbond Ltd DWTX Common Stock Conversion of derivative security 2,842,638 2,842,638 21 Nov 2025 By Conjoint Inc.
Sealbond Ltd DWTX Common Stock Conversion of derivative security 10223.6% 21,610,950 21,822,333 21 Nov 2025 Direct
Sealbond Ltd DWTX Series A-1 Preferred Stock Conversion of derivative security -100% -284 0 21 Nov 2025 By Conjoint Inc.
Sealbond Ltd DWTX Series A Preferred Stock Conversion of derivative security -100% -2,161 0 21 Nov 2025 Direct
Roger Michael Gendreau DWTX Stock Option (right to buy) Award 12,075 12,075 27 Jun 2025 Direct
Richard James Whitley DWTX Stock Option (right to buy) Award 2,362 2,362 27 Jun 2025 Direct
Ralph Grosswald DWTX Stock Option (right to buy) Award 12,075 12,075 27 Jun 2025 Direct
John C. Thomas DWTX Stock Option (right to buy) Award 2,362 2,362 27 Jun 2025 Direct
Gregory Scott Duncan DWTX Stock Option (right to buy) Award 40,000 40,000 27 Jun 2025 Direct
David R. Keefer DWTX Stock Option (right to buy) Award 2,362 2,362 27 Jun 2025 Direct
Angela Walsh DWTX Stock Option (right to buy) Award 12,075 12,075 27 Jun 2025 Direct
Abel de la Rosa DWTX Stock Option (right to buy) Award 2,362 2,362 27 Jun 2025 Direct
Richard James Whitley DWTX Stock Option (right to buy) Award 420 420 18 Jun 2025 Direct
David R. Keefer DWTX Stock Option (right to buy) Award 420 420 18 Jun 2025 Direct
John C. Thomas DWTX Stock Option (right to buy) Award 420 420 18 Jun 2025 Direct
Abel de la Rosa DWTX Stock Option (right to buy) Award 420 420 18 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.